COVID-19 (SARS-CoV-2) infection Clinical Trials in Washington D.C., District of Columbia

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease